CClinicalTrials.gg
CompletedNCT04442906Updated Jan 25, 2021

Analgesia After Knee Arthroscopy :Dexmedetomidine vs Fentanyl

An interventional study of Dexmedetomidine and Fentanyl in Analgesia, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to participants aged 21 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-01-25.

Sponsored by Zagazig University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
21 Years to 45 Years
Sex
All
01

Study summary

The aim of this study is to evaluate analgesic effects Bupivacaine, Bupivacaine plus Dexmedetomidine and Bupivacaine plus Fentanyl in relieving pain after knee arthroscopic surgery.

Read the detailed description

Forty-five patients ASA I - II aged 21-45 years for elective knee arthroscopy were divided into 3 groups: Group B, BD and BF. Group B received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml saline. Group BD received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml dexmedetomidine (100 ug).

Group BF received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 fentanyl (50 ug). The time of first request of analgesia and analgesic effect by VAS during the first 24 hr. postoperatively are recorded.

02

Conditions studied

  • Analgesia

Browse trials for

Keywords

  • dexmedetomidine
  • fentanyl
  • bupivacaine
  • knee arthroscopy
  • postoperative analgesia
03

In context

Agnosia

1,189 studies on the registry are indexed under Agnosia; 507 are open to participants now.

This study's enrollment of 45 is below the median of 77 across 1,023 interventional studies indexed under Agnosia.

Browse Agnosia studies →

Lead sponsor

Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Either sex,
  • Age 21-45 years,
  • American Society of Anesthesia (ASA) I - II for elective knee arthroscopy.

Exclusion criteria

Exclusion Criteria:

  • The patients with history of hepatic and renal diseases, psychiatric disorders,
  • Prolonged intake of (NSAIDS, opioids and tricyclic antidepressant),
  • Allergy to study drugs and patient who received analgesics up to 24 hr. before surgery were excluded from this study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
45 participants (actual)

Study arms

  • Active comparator
    group B

    IGroup B received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml saline

    Drug: Bupivacain

  • Active comparator
    group BD

    . Group BD received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml dexmedetomidine (100 ug).

    Drug: Dexmedetomidine · Drug: Bupivacain

  • Active comparator
    group BF

    Group BF received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 fentanyl (50 ug).

    Drug: Fentanyl · Drug: Bupivacain

Interventions

  • DrugDexmedetomidine

    Group BD received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml dexmedetomidine (100 ug).

    Also known as: precedex

  • DrugFentanyl

    Group BF received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 fentanyl (50 ug)

  • DrugBupivacain

    Group B received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 ml saline.

    Also known as: marcaine

06

What researchers measure

Primary outcomes

  1. Duration of postoperative analgesia

    start from intra-articular injection of the drug to the time of first request of analgesia

    Time frame: For 24 hours postoperative

Secondary outcomes

  1. total dose of rescue analgesia ( pethidine)

    total consumption of rescue analgesia (pethidine) postoperative

    Time frame: within 24 hours postoperative

  2. The number of participants with bradycardia, itching and hypotension

    The number of participants with bradycardia less than 50 beat per minute, itching and hypotension if mean arterial blood pressure less than 20% of basal )

    Time frame: Within 24 hours postoperative

  3. patient satisfaction

    Patient satisfaction by five point Likert-Like verbal rating scale by asking the patient how they evaluate the experience with the analgesic management after the the surgery? (5-very satisfied, 4-satisfied, 3-neutral, 2-dissatisfied, 1-very dissatisfied)

    Time frame: within 24 hours postoperative

  4. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale (0- no pain and 10-the worst pain)

    Time frame: measured immediately preoperative 0 minute ( admission receiving area)

  5. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 30 minutes postoperative

  6. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 1 hour postoperative

  7. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 2 hours postoperative

  8. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 4 hours postoperative

  9. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 6 hours postoperative

  10. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 8 hours postoperative

  11. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 12 hours postoperative

  12. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 18 hours postoperative

  13. pain intensity at rest (static)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 24 hours postoperative

  14. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: measured immediately preoperative 0 minute ( admission receiving area)

  15. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 30 minutes postoperative

  16. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 1 hours postoperative

  17. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 2 hours postoperative

  18. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 4 hours postoperative

  19. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 6 hours postoperative

  20. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 8 hours postoperative

  21. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 12 hours postoperative

  22. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 18 hours postoperative

  23. pain intensity on mobilization of operated knee (dynamic)

    measured by VAS on 0-10 cm scale(0- no pain and 10-the worst pain)

    Time frame: at 24 hours postoperative

07

Study locations

1 site
  • Zagazig university
    Zagazig, Egypt
08

References and documents

Publications

  • Salem DAE, Nabi SMA, Alagamy SA, Kamel AAF. Comparative Study Between Dexmedetomidine and Fentanyl as an Adjuvant to Intraarticular Bupivacaine for Postoperative Analgesia after Knee Arthroscopy. Pain Physician. 2021 Nov;24(7):E989-E996. PubMed 34704709 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 25, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04442906
Lead sponsor
Zagazig University
Responsible party
Dina Abdelhameed Elsadek Salem (Principle investigator, Zagazig University) — Principal investigator
First posted
Jun 23, 2020
Start date
Jul 1, 2020
Primary completion
Nov 1, 2020
Completion
Dec 1, 2020
Last update
Jan 25, 2021

Study contacts

Dina Salem, MD.
principal investigator · faculty of medicine , Zagazig University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion